Blonder Tongue Laboratories, Inc. Stock

Equities

BDRL

US0936981085

Communications & Networking

Market Closed - OTC Markets 11:35:52 2024-04-23 am EDT 5-day change 1st Jan Change
0.149 USD -20.77% Intraday chart for Blonder Tongue Laboratories, Inc. +83.95% +82.82%
Sales 2021 15.75M Sales 2022 18.12M Capitalization 2.57M
Net income 2021 - Net income 2022 -2M EV / Sales 2021 0.83 x
Net Debt 2021 5.59M Net Debt 2022 10.72M EV / Sales 2022 0.73 x
P/E ratio 2021
85.3 x
P/E ratio 2022
-0.87 x
Employees 67
Yield 2021 *
-
Yield 2022
-
Free-Float 61.66%
More Fundamentals * Assessed data
Dynamic Chart
Blonder Tongue Announces IP Failover Feature Added to NXG Video Delivery System CI
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on February 13, 2007. CI
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on July 24, 2002. CI
Blonder Tongue Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Blonder Tongue Laboratories, Inc. Auditor Raises 'Going Concern' Doubt CI
Blonder Tongue Announces Demise of Eric Skolnik, Senior Vice President CI
Blonder Tongue Announces Demise of Eric Skolnik, Chief Financial Officer; Appoints Michael Censoplano as Interim CFO CI
Blonder Tongue Laboratories, Inc. Announces the Retirement of Stephen K. Necessary from the Board CI
Blonder Tongue Laboratories, Inc. Announces President Changes CI
Blonder Tongue Laboratories, Inc. Announces Chief Executive Officer Changes CI
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on July 24, 2002. CI
Tranche Update on Blonder Tongue Laboratories, Inc.'s Equity Buyback Plan announced on February 13, 2007. CI
Transcript : Blonder Tongue Laboratories, Inc., Q3 2022 Earnings Call, Nov 04, 2022
Blonder Tongue Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Earnings Flash (BDRL) BLONDER TONGUE LABORATORIES Posts Q3 Revenue $5.3M MT
More news
1 day-20.77%
1 week+83.95%
Current month+49.00%
1 month+35.45%
3 months+63.74%
6 months+35.45%
Current year+82.82%
More quotes
1 week
0.10
Extreme 0.1
0.19
1 month
0.08
Extreme 0.08
0.20
Current year
0.08
Extreme 0.08
0.20
1 year
0.06
Extreme 0.0601
0.29
3 years
0.06
Extreme 0.0601
1.91
5 years
0.06
Extreme 0.0601
3.80
10 years
0.06
Extreme 0.0601
3.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 78 89-03-31
Director of Finance/CFO 51 23-02-22
Sales & Marketing - -
Members of the board TitleAgeSince
Chief Executive Officer 78 89-03-31
Director/Board Member 68 97-11-30
Director/Board Member 66 93-08-31
More insiders
Date Price Change Volume
24-04-23 0.149 -20.77% 500
24-04-22 0.188 +88.00% 2,103
24-04-19 0.1 -50.00% 367
24-04-18 0.2 +146.91% 880
24-04-17 0.081 -57.14% 1,230

Delayed Quote OTC Markets, April 23, 2024 at 11:35 am EDT

More quotes
Blonder Tongue Laboratories, Inc., along with its subsidiary R. L. Drake Holdings, LLC (Drake), is a technology research and development company. The Company delivers a range of products and services to telecommunications, cable and fiber optic service delivery operators, as well as broadcasters and media production companies. Its products are deployed in a list of locations, including lodging/hospitality, multi-dwelling units/apartments, broadcast studios/networks, universities/schools, healthcare/hospitals, fitness centers, government facilities/offices, prisons, airports, sports stadiums/arenas, entertainment venues/casinos, retail stores, and small-medium businesses. The Company’s products are divided into five categories: Encoders and Transcoders, NeXgen Gateway (NXG), Coax Distribution, consumer premise equipment (CPE) and Digital Modulation. Its Encoder/Transcoder Products are used by a system operator for encoding and transcoding of digital video.
More about the company